Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia

被引:0
|
作者
Uminski, Kelsey [1 ]
Khalife, Roy [1 ]
Fulcher, Jill [1 ]
Duffett, Lisa [1 ]
Wang, Tzu-Fei [1 ]
Tinmouth, Alan [1 ]
机构
[1] Univ Ottawa, Dept Med, Div Hematol, 501 Smyth Rd,Box 201A, Ottawa, ON K1H 8L6, Canada
关键词
DISORDERS; DECREASE;
D O I
10.1007/s00277-021-04688-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1137 / 1139
页数:3
相关论文
共 50 条
  • [11] 6-MERCAPTOPURINE CUMULATIVE DOSE - A CRITICAL FACTOR OF MAINTENANCE THERAPY IN AVERAGE RISK CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    DIBENEDETTO, SP
    GUARDABASSO, V
    RAGUSA, R
    DICATALDO, A
    MIRAGLIA, V
    DAMICO, S
    IPPOLITO, AM
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (03) : 251 - 258
  • [12] Isolated Factor VII Deficiency in a Child With Acute Lymphoblastic Leukemia at Presentation
    Arias, T.
    Zanabili Al-Sibai, J.
    Gonzalez, S.
    Fonseca, A.
    Bernardo, A.
    Palomo, M. P.
    Soto, I.
    HAEMOPHILIA, 2017, 23 : 134 - 134
  • [13] MERCAPTOPURINE VS THIOGUANINE FOR THE TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA
    EVANS, WE
    RELLING, MV
    LEUKEMIA RESEARCH, 1994, 18 (11) : 811 - 814
  • [14] Severe mercaptopurine-induced hypoglycemia in acute lymphoblastic leukemia
    Rebelo, Alicia
    Oliveira, Joana
    Sousa, Catia
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 37 (03) : 245 - 247
  • [15] Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
    Tiphaine Adam de Beaumais
    Evelyne Jacqz-Aigrain
    European Journal of Clinical Pharmacology, 2012, 68 : 1233 - 1242
  • [16] THE CYTOTOXICITY OF THIOGUANINE VS MERCAPTOPURINE IN ACUTE LYMPHOBLASTIC-LEUKEMIA
    ADAMSON, PC
    POPLACK, DG
    BALIS, FM
    LEUKEMIA RESEARCH, 1994, 18 (11) : 805 - 810
  • [17] ADHERENCE TO MERCAPTOPURINE AND HABIT STRENGTH IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    Yang, Mira
    Singh, Revika
    King, Kathryn
    Badawy, Sherif
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S59 - S60
  • [18] ALLOPURINOL USE WITH 6-MERCAPTOPURINE IN MAINTENANCE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
    Phillips, Lia
    Minson, Katherine
    Castellino, Sharon
    Bergsagel, John
    Lew, Glen
    Sabnis, Himalee
    Pauly, Melinda
    Keller, Frank
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [19] ALLOPURINOL USE DURING MAINTENANCE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA AVOIDS MERCAPTOPURINE RELATED HEPATOTOXICITY
    Giamanco, Nicole
    Foster, Laura
    Parekh, Dina
    Warwick, Anne
    Lieuw, Kenneth
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S24 - S24
  • [20] Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia
    Nielsen, Stine Nygaard
    Grell, Kathrine
    Nersting, Jacob
    Frandsen, Thomas Leth
    Hjalgrim, Lisa Lyngsie
    Schmiegelow, Kjeld
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (05) : 983 - 994